Joerg Breitkreutz studied Pharmacy at the Westfälische WilhelmsUniversity (WWU) in Münster and received his doctorate degree in pharmaceutical technology from this university in 1996 for his work on drug or excipients interactions with polyethylene glycols investigated by Molecular Modelling technologies, supervised by Dr. Georg Heun and Prof. Dr. Rüdiger Gröning. After almost 2 years of industrial experience as the Head of Product Coordination at Thiemann Arzneimittel GmbH in Waltrop, Germany (subsidiary of Organon, The Netherlands) he went back to WWU Muenster for his habilitation on “Paediatric drug formulations” which he finalized in 2004. Shortly before that, he joined the Heinrich Heine University (HHU) Düsseldorf as Professor for Pharmaceutical Technology and Biopharmaceutics. Since 2011, he is the director of the Institute of Pharmaceutics and Biopharmaceutics at HHU. His research topics include drug development for special patient populations such as children and the elderly, orphan drugs and process analytical technologies. In 2010, he became president of APV and maintained this position until March 2024. Since April 2024 he is vice president. He also serves as a German delegate and the chair of the PaedForm Working Party at the European Directorate for Quality and Healthcare (EDQM) in Strasbourg, France.